4//SEC Filing
DARGAN CHARLES K 4
Accession 0001437749-23-008072
CIK 0000880242other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 6:32 PM ET
Size
5.8 KB
Accession
0001437749-23-008072
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
DARGAN CHARLES K
Chief Financial Officer
Transactions
- Award
Option to purchase common stock
2023-03-21+300,000→ 4,331,500 totalExercise: $0.20From: 2023-03-21Exp: 2033-03-21→ Common stock (300,000 underlying)
Footnotes (2)
- [F1]The Option is exercisable according to its vesting schedule: (i) 25,000 shares vested as of March 21, 2023, and then (ii) in equal monthly installments of 25,000 shares beginning March 31, 2023, so long as the Engagement Extension Agreement dated March 21, 2023, between Reporting Person and Issuer, remains in force and effect.
- [F2]This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2023, through January 31, 2024.
Documents
Issuer
BIOLARGO, INC.
CIK 0000880242
Entity typeother
Related Parties
1- filerCIK 0001112799
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 6:32 PM ET
- Size
- 5.8 KB